Yoshiari Shimmyo

746 total citations
13 papers, 614 citations indexed

About

Yoshiari Shimmyo is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Yoshiari Shimmyo has authored 13 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Yoshiari Shimmyo's work include Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Fibroblast Growth Factor Research (2 papers). Yoshiari Shimmyo is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Fibroblast Growth Factor Research (2 papers). Yoshiari Shimmyo collaborates with scholars based in Japan, United States and Germany. Yoshiari Shimmyo's co-authors include Takeshi Kihara, Hachiro Sugimoto, Tetsuhiro Niidome, Akinori Akaike, Yutaka Sadakane, Kirsten J. Lampi, Y. Morimoto, Noriko Fujii, Toshiro Kinouchi and Yuhei Goto and has published in prestigious journals such as Nature Communications, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Yoshiari Shimmyo

13 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiari Shimmyo Japan 10 273 192 190 107 89 13 614
Yael Avramovich‐Tirosh Israel 8 341 1.2× 224 1.2× 222 1.2× 118 1.1× 99 1.1× 9 926
Niloufar Ansari Iran 19 154 0.6× 351 1.8× 140 0.7× 103 1.0× 88 1.0× 32 898
Xueting Du China 8 287 1.1× 164 0.9× 111 0.6× 66 0.6× 58 0.7× 15 534
Yajing Su China 6 249 0.9× 178 0.9× 123 0.6× 97 0.9× 58 0.7× 16 575
Grant Stuchbury Australia 10 254 0.9× 240 1.3× 131 0.7× 51 0.5× 34 0.4× 10 747
Priyanka Parihar India 9 173 0.6× 223 1.2× 112 0.6× 101 0.9× 78 0.9× 16 641
Isha Solanki India 5 146 0.5× 191 1.0× 106 0.6× 93 0.9× 75 0.8× 5 557
Doug Shytle United States 6 547 2.0× 219 1.1× 206 1.1× 139 1.3× 75 0.8× 8 948
Kasthuri Bai Magalingam Malaysia 9 127 0.5× 225 1.2× 90 0.5× 99 0.9× 108 1.2× 19 591
Natalia P. Alza Argentina 10 105 0.4× 165 0.9× 201 1.1× 90 0.8× 66 0.7× 15 531

Countries citing papers authored by Yoshiari Shimmyo

Since Specialization
Citations

This map shows the geographic impact of Yoshiari Shimmyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiari Shimmyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiari Shimmyo more than expected).

Fields of papers citing papers by Yoshiari Shimmyo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiari Shimmyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiari Shimmyo. The network helps show where Yoshiari Shimmyo may publish in the future.

Co-authorship network of co-authors of Yoshiari Shimmyo

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiari Shimmyo. A scholar is included among the top collaborators of Yoshiari Shimmyo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiari Shimmyo. Yoshiari Shimmyo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Suzuki, Keiichiro, Emi Aizawa, Yoshichika Yoshioka, et al.. (2022). Establishment of mouse model of inherited PIGO deficiency and therapeutic potential of AAV-based gene therapy. Nature Communications. 13(1). 3107–3107. 9 indexed citations
2.
Sakai, Hiroki, Hidekazu Inoue, Kenji Murata, et al.. (2020). Fibroblast growth factor receptor modulators employing diamines with reduced phospholipidosis-inducing potential. Bioorganic & Medicinal Chemistry. 28(14). 115562–115562. 9 indexed citations
3.
Imagama, Shiro, Shinya Ueno, Norihito Murayama, et al.. (2020). Systemic treatment with a novel basic fibroblast growth factor mimic small-molecule compound boosts functional recovery after spinal cord injury. PLoS ONE. 15(7). e0236050–e0236050. 7 indexed citations
4.
Inoue, Hidekazu, et al.. (2019). Discovery of 1,2,3-triazole-based fibroblast growth factor receptor modulators. Bioorganic & Medicinal Chemistry Letters. 29(16). 2332–2337. 7 indexed citations
5.
Suzuki, Ryosuke O., Shigeki Tamura, Yoshiari Shimmyo, et al.. (2018). Synthesis and evaluation of N-(4-benzylphenyl)piperazines as VGF inducers. Bioorganic & Medicinal Chemistry Letters. 28(14). 2528–2532. 1 indexed citations
6.
Murayama, Norihito, Taisuke Kadoshima, Shiho Kodama, et al.. (2012). SUN11602, a Novel Aniline Compound, Mimics the Neuroprotective Mechanisms of Basic Fibroblast Growth Factor. ACS Chemical Neuroscience. 4(2). 266–276. 11 indexed citations
7.
Kihara, Takeshi, Yoshiari Shimmyo, Akinori Akaike, Tetsuhiro Niidome, & Hachiro Sugimoto. (2010). Abeta-induced BACE-1 cleaves N-terminal sequence of mPGES-2. Biochemical and Biophysical Research Communications. 393(4). 728–733. 11 indexed citations
8.
Shimmyo, Yoshiari, Takeshi Kihara, Akinori Akaike, Tetsuhiro Niidome, & Hachiro Sugimoto. (2008). Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation. Neuroreport. 19(13). 1329–1333. 89 indexed citations
9.
Shimmyo, Yoshiari, Takeshi Kihara, Akinori Akaike, Tetsuhiro Niidome, & Hachiro Sugimoto. (2008). Flavonols and flavones as BACE-1 inhibitors: Structure–activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochimica et Biophysica Acta (BBA) - General Subjects. 1780(5). 819–825. 195 indexed citations
10.
Shimmyo, Yoshiari, Takeshi Kihara, Akinori Akaike, Tetsuhiro Niidome, & Hachiro Sugimoto. (2008). Three distinct neuroprotective functions of myricetin against glutamate‐induced neuronal cell death: Involvement of direct inhibition of caspase‐3. Journal of Neuroscience Research. 86(8). 1836–1845. 76 indexed citations
11.
Shimmyo, Yoshiari, Takeshi Kihara, Akinori Akaike, Tetsuhiro Niidome, & Hachiro Sugimoto. (2007). Multifunction of myricetin on Aβ: Neuroprotection via a conformational change of Aβ and reduction of Aβ via the interference of secretases. Journal of Neuroscience Research. 86(2). 368–377. 100 indexed citations
12.
Kihara, Takeshi, et al.. (2006). Distinct mechanisms underlie distinct polyphenol‐induced neuroprotection. FEBS Letters. 580(28-29). 6623–6628. 59 indexed citations
13.
Fujii, Noriko, Yoshiari Shimmyo, Yutaka Sadakane, et al.. (2006). Age-related changes of alpha-crystallin aggregate in human lens. Amino Acids. 32(1). 87–94. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026